NSE · WINDLAS
Windlas Biotech Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,156
of 5,004 stocks
🏆 New peak
▲ 31W
Peak #1,156 · 01 Oct 2026
Operating in Healthcare, Windlas Biotech Limited remains firmly promoter-controlled, with promoters holding 63%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
2,252.01 Cr
P/E Ratio
34.53
P/B Ratio
3.97
ROE
11.44%
ROCE
15.65%
Dividend Yield
0.58%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 248.10 Cr | 238.50 Cr | 233.10 Cr | 222.40 Cr |
| Net Profit | 17.65 Cr | 15.99 Cr | 15.00 Cr | 17.80 Cr |
| EPS | 8.46 | 7.58 | 7.12 | 8.48 |
| Operating Profit | 24.59 Cr | 21.64 Cr | 21.25 Cr | 24.60 Cr |
Shareholding pattern
Promoter
63.31%
Public
36.69%
Mutual fund holdings
₹58.73
Cr total
3
Schemes
3
Fund Houses
₹58.73 Cr
Total Exposure
ICICI Prudential Mutual Fund₹40.17 Cr (68.4%)
UTI Mutual Fund₹18.53 Cr (31.6%)
Motilal Oswal Mutual Fund₹0.02 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 16 Jul 2026 | Dividend | Dividend - Rs 6.30 Per Share |
| 24 Apr 2026 | Buyback | Buy Back |
| 21 Jul 2025 | Dividend | Dividend - Rs 5.80 Per Share |
| 17 Sep 2024 | Other | Annual General Meeting |
| 17 Sep 2024 | Dividend | Dividend - Rs 5.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.